These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1355489)

  • 1. Dopaminergic stimulation of oxytocin concentrations in the plasma of male and female monkeys by apomorphine and a D2 receptor agonist.
    Cameron JL; Pomerantz SM; Layden LM; Amico JA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):855-60. PubMed ID: 1355489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin and vasopressin secretion in monkeys administered apomorphine and a D2 receptor agonist.
    Amico JA; Layden LM; Pomerantz SM; Cameron JL
    Life Sci; 1993; 52(15):1301-9. PubMed ID: 8096618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic influences on male sexual behavior of rhesus monkeys: effects of dopamine agonists.
    Pomerantz SM
    Pharmacol Biochem Behav; 1992 Mar; 41(3):511-7. PubMed ID: 1350100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxytocin secretory response to dopamine receptor agonists in male and female monkeys.
    Amico JA; Pomerantz SM; Layden LM; Cameron JL
    Ann N Y Acad Sci; 1992 Jun; 652():478-80. PubMed ID: 1626854
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinelorane (LY163502), a D2 dopamine receptor agonist, acts centrally to facilitate penile erections of male rhesus monkeys.
    Pomerantz SM
    Pharmacol Biochem Behav; 1991 May; 39(1):123-8. PubMed ID: 1833778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
    Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC
    Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
    Rajakumar N; Laurier L; Niznik HB; Stoessl AJ
    Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor subtype-specific dopaminergic agents and unconditioned behavior.
    Beninger RJ; Mazurski EJ; Hoffman DC
    Pol J Pharmacol Pharm; 1991; 43(6):507-28. PubMed ID: 1687945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine facilitates male sexual behavior of rhesus monkeys.
    Pomerantz SM
    Pharmacol Biochem Behav; 1990 Mar; 35(3):659-64. PubMed ID: 2339155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    J Pharmacol Exp Ther; 1997 Nov; 283(2):794-9. PubMed ID: 9353400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent D2 effects on genital reflexes after MPOA injections of quinelorane and apomorphine.
    Bazzett TJ; Eaton RC; Thompson JT; Markowski VP; Lumley LA; Hull EM
    Life Sci; 1991; 48(24):2309-15. PubMed ID: 1828516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
    Meschler JP; Clarkson FA; Mathews PJ; Howlett AC; Madras BK
    J Pharmacol Exp Ther; 2000 Mar; 292(3):952-9. PubMed ID: 10688609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats.
    Verma A; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1993; 324():17-32. PubMed ID: 7905255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.